Importantly, TNF-α has been shown to increase the subpopulation of breast cancer stem-like cells: via non-canonical NF-κB, TNF-α upregulates TAZ, a transcriptional co-activator in the Hippo pathway, thereby enriching tumor-initiating cells that drive recurrence and chemotherapy resistance. The gene discussed is NFKB1; the disease is neoplasm.